An article by our collaborator Irene Tarragó

My name is David and I’m president of an Association to raise awareness of Epilepsy “Si jo puc, tu també #epilep” (If I can, so can you). I was first diagnosed with epilepsy when I was 6, now I’m 49, but for many years I didn’t have any crises. For some time now, I am resistant to medication, meaning that it doesn’t have as much effect as it should, and I therefore have several crises per day. There was even a period when I was having upto 15 crises every day.

Despite having a cronic illness, I have always tried to maintain an active life. I studied, I was able to do a job I enjoyed (I managed to become the Head of Marketing for a sector of a multinational company), etc.

Nowadays, as my epilepsy is not under control, I’m not able to work, but that doesn’t mean that I can’t deal with the illness in a positive and optimistic way. I firmly believe that a positive attitude and state of mind greatly improves your everyday life, and that of those around you.

At the moment, I’m trying to raise awareness and improve understanding of epilepsy through the Association, through sports events, as, for many years, these kinds of sports were considered impossible for those with epilepsy. I also want to demonstrate that those of us with epilepsy can do many things. We should all follow our dreams, challenge ourselves in life.

“For a long time it was believed that people with epilepsy could not participate in sporting events”

Little by little the Association has been growing, and right now we have various projects underway, and others on hold until Covid-19 or finances permit. All of our activities are free.

  • Weekly walks around Tarragona, which serve to raise awareness of epilepsy and be in contact with the local community. Social inclusion is fundamental for us, so you don’t need to be epileptic or a family member… we are open to everyone. This is how we can all learn from each other.
  • We participate in races organised by other organisations. We have created an organisation called “Quilòmetres per l’epilèpsia”, which takes place on 24th May to celebrate Epilepsy Day. What we want is to raise awareness of epilepsy covering kilometres in every possible way (walking, running, swimming, dancing, etc). Last year we presented 525 participants, and covered 6,000km. (spanish version video)
  • Fundraising for research : through donations for our sports kit items, and the registration fee for events we organise, we make donations for research.
  • Iberoamerican Epilepsy Network: we are one of the founders of this network. It is designed to join together our efforts, knowledge and experience at an international level, with training courses etc.
  • Training in schools: this project consists of presentations for both primary and secondary schools, to explain what epilepsy is, and for the pupils to be in contact with a person with the illness. Our goal is to get rid of stigmas and bullying in schools, aswell as to educate the teaching staff.

If you are intersted in collaborating with us, or if you have any questions, you can contact us on our social networks:


In summary, good habits (nutrition and exercise), a positive attitude and state of mind, and being active are of signifcant benefit for you to maintain a full life.

Many thanks.

David Sanahuja.

Leave a Reply

Open chat
Contact with us now
Chat with Anna
¡Hola! 👋🏻
Soy Anna, ¿en qué puedo ayudarte?

The user who fills in the information requested in this form declares to be entitled to do so and is solely responsible for the accuracy and completeness of the data and information entered, expressly exonerating MJN NEUROSERVEIS of any liability that may arise for this entity on the occasion of the information provided through this form.

Yes, I accept

L’usuari que complimenta la informació requerida al present formulari declara estar legitimat per això i es fa responsable exclusiu de la veracitat i integritat de les dades i informació que introdueix, exonerant expressament a MJN NEUROSERVEIS de qualsevol responsabilitat que es pugi generar per aquesta entitat amb ocasió de la informació facilitat a través del present formulari.

Si, accepto

El usuario que cumplimenta la información requerida en el presente formulario declara estar legitimado para ello y se hace responsable exclusivo de la veracidad e integridad de los datos e información que introduce, exonerando expresamente a MJN NEUROSERVEIS de cualquier responsabilidad que pudiera generarse para esta entidad con ocasión de la información facilitada a través del presente formulario.

Sí, acepto

Save the date

The next Saturday 21st of November at 4 pm, you will be able to know first hand our product: mjn-SERAS.
mjn-SERAS is a healthcare product that sends a warning signal when the risk of epileptic seizures is high, to the affected person and their trusted contacts.

Sign up now!

    mjn-SERAS is a medical device with CE marking according to the European Directive 93/42/EEC and the Royal Decree RD. 1591/2009.
    Contraindications: Do not use the product if you suffer from an infection in the ear canal or if you suffer from a skin lesion in the vicinity of the product's area of influence.
    Considerations: This medical product works with an APP only on Android phones. The results tested are 96% sensitivity and 94% specificity.

    Save the date

    El próximo sábado 21 de noviembre a las 4 de la tarde, podrás conocer de primera mano nuestro producto: mjn-SERAS.
    mjn-SERAS es un producto sanitario que lanza una señal de aviso cuando el riesgo de crisis de epilepsia es elevado, a la persona afectada y a sus contactos de confianza.


      mjn-SERAS es un producto sanitario con marcado CE conforme a la Directiva Europea 93/42/EEC y el Real Decreto RD. 1591/2009.
      Contraindicaciones: No usar el producto en caso de padecer una infección en el canal auditivo o en caso de padecer una lesión cutánea en las proximidades del área de influencia del producto.
      Consideraciones: Este producto sanitario funciona con una APP solo en teléfonos Android. Los resultados testeados son 96% de sensibilidad y 94% de especificidad.